Anzeige
Mehr »
Samstag, 07.03.2026 - Börsentäglich über 12.000 News
USA erklären Kupfer zur Chefsache - dieser Nevada-Explorer bohrt bereits
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrAlnylam and Tenaya sign $1.23bn cardiovascular target discovery deal
FrJ&J announces Tecvayli-Darzalex combo approval from FDA for multiple myeloma
FrLiberate Bio gains licences for myeloid-specific CAR design patents
DoModerna pays up to $2.25bn to settle drug delivery tech patent lawsuit
DoCordenPharma leases space at Flatiron Park for peptides development
DoPharmaceutical Technology's parent company GlobalData moves to Main Market of LSE
DoAffinia receives FDA fast track designation for AFTX-201
MiSanofi bets on Sino Biopharm's transplant drug in $1.5bn licensing deal
MiAspire Biopharma and Microsize collaborate for alprazolam powder formulation
MiEsperion to acquire Corstasis for cardiovascular franchise expansion
DiOSE narrows pipeline focus amid Boehringer MASH collaboration retreat
DiPharma rings the changes as CEO shake-up continues
DiRallybio to acquire Candid Therapeutics
DiNovo Nordisk starts €432m Ireland facility upgrade for oral Wegovy production
DiKairos Pharma signs deal for Celyn Therapeutics' CL-273
MoModerna's dual Covid-flu vaccine poised for EMA approval on positive CHMP take
MoSanofi receives CHMP recommendation for Dupixent expansion in Europe
MoFDA approves Ascendis Pharma's weekly Yuviwel for paediatric dwarfism
MoSanofi receives CHMP recommendation for Dupixent approval in Europe
MoBioMarin receives FDA approval for Palynziq use in adolescents
27.02.Boehringer inks $500m Sitryx deal, secures CPNV-driven Hernexeos approval
27.02.Generate Biomedicines secures $400m IPO in flurry of February listings
27.02.Asahi Kasei to acquire Aicuris Anti-infective Cures for $920.7m
27.02.Quotient and Ipsen extend partnership for ultra-rare disease therapy
26.02.MHRA and police seize 2,000 illegal weight loss drugs after raiding criminal facility